NEXGEL, Inc. (NXGL)
NASDAQ: NXGL · Real-Time Price · USD
3.300
+0.040 (1.23%)
Nov 20, 2024, 4:00 PM EST - Market closed
NEXGEL Market Cap
NEXGEL has a market cap or net worth of $24.81 million as of November 21, 2024. Its market cap has increased by 138.01% in one year.
Market Cap
24.81M
Enterprise Value
26.96M
1-Year Change
138.01%
Ranking
Category
Stock Price
$3.30
Market Cap Chart
Since the IPO on December 22, 2021, NEXGEL's market cap has increased from $19.59M to $24.81M, an increase of 26.65%. That is a compound annual growth rate of 8.44%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 20, 2024 | 24.81M | 103.72% |
| Dec 29, 2023 | 12.18M | 74.85% |
| Dec 30, 2022 | 6.97M | -52.05% |
| Dec 31, 2021 | 14.52M | -25.85% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| MIRA Pharmaceuticals | 22.90M |
| Chemomab Therapeutics | 22.69M |
| XTL Biopharmaceuticals | 22.48M |
| Bolt Biotherapeutics | 22.16M |
| Neuronetics | 22.00M |
| Bionano Genomics | 21.79M |
| NeurAxis | 21.64M |
| Enlivex Therapeutics | 21.62M |